Publicaciones en las que colabora con Jaime Sanz Caballer (31)

2024

  1. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil

    Transplantation and Cellular Therapy, Vol. 30, Núm. 10, pp. 1025.e1-1025.e14

  2. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

    Blood Advances, Vol. 8, Núm. 15, pp. 3985-3992

  3. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

    Transplantation and Cellular Therapy, Vol. 30, Núm. 2, pp. 210.e1-210.e14

  4. Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy

    Bone Marrow Transplantation, Vol. 59, Núm. 1, pp. 93-100

2023

  1. Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?

    Clinical Microbiology and Infection

2022

  1. Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

    Bone Marrow Transplantation, Vol. 57, Núm. 9, pp. 1389-1398

2021

  1. Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysis

    HLA, Vol. 97, Núm. 3, pp. 198-213

  2. An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation

    Journal of Medical Virology, Vol. 93, Núm. 8, pp. 4773-4779

  3. Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

    European Journal of Haematology, Vol. 106, Núm. 1, pp. 114-125

  4. Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation

    Transplant Infectious Disease, Vol. 23, Núm. 3

2020

  1. Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation

    Transplant Infectious Disease, Vol. 22, Núm. 4

  2. Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens

    Journal of Infection

  3. Cytomegalovirus DNA load monitoring in stool specimens for anticipating the occurrence of intestinal acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: Is it of any value?

    Transplant Infectious Disease, Vol. 22, Núm. 6

  4. Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

    Leukemia and Lymphoma, pp. 1-10

  5. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies

    Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 2, pp. 358-366

  6. The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey

    Bone Marrow Transplantation, Vol. 55, Núm. 2, pp. 431-440

  7. Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors

    Bone Marrow Transplantation, Vol. 55, Núm. 11, pp. 2147-2159

2019

  1. Clinical Effectiveness of Influenza Vaccination after Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study

    Clinical Infectious Diseases, Vol. 68, Núm. 11, pp. 1894-1903

  2. Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

    European Journal of Haematology, Vol. 102, Núm. 6, pp. 465-471

  3. Haploidentical Stem Cell Transplantation with Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults with Hematologic Cancers: A Systematic Review and Meta-Analysis

    JAMA Oncology, Vol. 5, Núm. 12, pp. 1739-1748